We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




International RNA Project

By Biotechdaily staff writers
Posted on 29 Mar 2005
An international team of RNA scientists, called the RNA Ontology Consortium, has been formed to develop a shared vocabulary and system for describing, cataloging, and comparing RNA findings.

RNA research has been exploding in recent years as scientists worldwide discover the role of RNA in genetics, health, disease, and the development of organisms. More...
Creating the new consortium will require incorporating the methods and vocabularies of chemists, molecular biologists, genomicists, information scientists, and structural biologists. The ontology team will identify all RNA motifs, or repeated patterns, mentioned in the literature or appearing in databases in order to agree upon and write a definition for each motif. The consortium's work will be accessible on the Internet to the various RNA research communities.

"The consortium will develop a common vocabulary and scientific concepts relating RNA structure and function to allow RNA scientists worldwide to communicate with one another as well as to integrate different kinds of information they obtain about RNA molecules,” explained Dr. Neocles Leontis, professor of chemistry at Bowling Green State University (OH, USA), chosen by the RNA Society to head the consortium and serve as principal investigator.

The U.S. National Science Foundation is providing U.S.$500,000 for the five-year project as one of its Research Coordination Networks. The consortium will include scientists from the United Kingdom, France, Australia, Canada, and the United States. Some researchers will focus on the sequences of RNA molecules, while others will study their three-dimensional (3D) structures. A major focus of the project will be to integrate the databases of RNA sequences and 3D structures.

"The hardware (proteins) for mice and humans is practically the same, but clearly mice and humans are different,” noted Dr. Leontis. "Since the hardware is the same, the difference between mice and humans must be at the software level, which determines how the hardware is used. We are beginning to see that RNA is that software.”






Related Links:
Bowling Green State U.

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.